{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:04:34Z","timestamp":1768352674847,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00120-020-01365-9","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T14:02:43Z","timestamp":1602511363000},"page":"1486-1491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Infektionskomplikationen bei Prostatabiopsie 2020 \u2013 Was hat sich ge\u00e4ndert?","Infectious complications following prostate biopsy\u2014Major changes 2020"],"prefix":"10.1007","volume":"59","author":[{"given":"A.","family":"Pilatz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bonkat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Wagenlehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"1365_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed\u00a0HU, El-Shater Bosaily\u00a0A, Brown\u00a0LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a\u00a0paired validating confirmatory study. Lancet 389:815\u2013822","journal-title":"Lancet"},{"key":"1365_CR2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jiac.2018.03.014","volume":"24","author":"K Baba","year":"2018","unstructured":"Baba\u00a0K, Sekine\u00a0Y, Miyazawa\u00a0Y et al (2018) Assessment of antimicrobiral prophylaxis in transperineal prostate biopsy: a single-center retrospective study of 485\u00a0cases. J\u00a0Infect Chemother 24:637\u2013640","journal-title":"J Infect Chemother"},{"key":"1365_CR3","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1017\/S0950268815002885","volume":"144","author":"HY Bennett","year":"2016","unstructured":"Bennett\u00a0HY, Roberts\u00a0MJ, Doi\u00a0SA et\u00a0al (2016) The global burden of major infectious complications following prostate biopsy. Epidemiol Infect 144:1784\u20131791","journal-title":"Epidemiol Infect"},{"key":"1365_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bju.15039","volume":"126","author":"B Berry","year":"2020","unstructured":"Berry\u00a0B, Parry\u00a0MG, Sujenthiran\u00a0A et al (2020) Comparison of complications after transrectal and transperineal prostate biopsy: a\u00a0national population-based study. BJU Int 126:97\u2013103","journal-title":"BJU Int"},{"key":"1365_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.eururo.2019.06.011","volume":"76","author":"G Bonkat","year":"2019","unstructured":"Bonkat\u00a0G, Pilatz\u00a0A, Wagenlehner\u00a0F (2019) Time to adapt our practice? The European commission has restricted the use of fluoroquinolones since march 2019. Eur Urol 76:273\u2013275","journal-title":"Eur Urol"},{"key":"1365_CR6","first-page":"5071","volume":"17","author":"S Brewster","year":"2010","unstructured":"Brewster\u00a0S, Turkeri\u00a0L, Brausi\u00a0M et\u00a0al (2010) 5A prospective survey of current prostate biopsy practices among oncological urologists. Can J Urol 17:5071\u20135076","journal-title":"Can J Urol"},{"key":"1365_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jgar.2018.11.020","volume":"17","author":"A Carignan","year":"2019","unstructured":"Carignan\u00a0A, Sabbagh\u00a0R, Masse\u00a0V et al (2019) Effectiveness of fosfomycin tromethamine prophylaxis in preventing infection following transrectal ultrasound-guided prostate needle biopsy: results from a\u00a0large Canadian cohort. J\u00a0Glob Antimicrob Resist 17:112\u2013116","journal-title":"J Glob Antimicrob Resist"},{"key":"1365_CR8","first-page":"93","volume":"21","author":"RS Concepcion","year":"2019","unstructured":"Concepcion\u00a0RS, Schaeffer\u00a0EM, Shore\u00a0ND et al (2019) The effect of local antibiogram-based augmented antibiotic prophylaxis on infection-related complications following prostate biopsy. Rev Urol 21:93\u2013101","journal-title":"Rev Urol"},{"key":"1365_CR9","unstructured":"European Commission (2019) https:\/\/ec.europa.eu\/transparency\/regdoc\/rep\/3\/2019\/EN\/C-2019-2050-F1-EN-ANNEX-1-PART-1.PDF"},{"key":"1365_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/2090598X.2019.1592636","volume":"17","author":"DMO Freitas","year":"2019","unstructured":"Freitas\u00a0DMO, Moreira\u00a0DM (2019) Fosfomycin trometamol vs ciprofloxacin for antibiotic prophylaxis before transrectal ultrasonography-guided prostate biopsy: a meta-analysis of clinical studies. Arab J Urol 17:114\u2013119","journal-title":"Arab J Urol"},{"key":"1365_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41391-020-0204-8","volume":"23","author":"J Grummet","year":"2020","unstructured":"Grummet\u00a0J, Gorin\u00a0MA, Popert\u00a0R et\u00a0al (2020) \u201cTREXIT 2020\u201d: why the time to abandon transrectal prostate biopsy starts now. Prostate Cancer Prostatic Dis 23:62\u201365","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1365_CR12","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.juro.2010.11.088","volume":"185","author":"MA Liss","year":"2011","unstructured":"Liss\u00a0MA, Chang\u00a0A, Santos\u00a0R et\u00a0al (2011) Prevalence and significance of fluoroquinolone resistant escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J\u00a0Urol 185:1283\u20131288","journal-title":"J Urol"},{"key":"1365_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.juro.2017.01.103","volume":"198","author":"MA Liss","year":"2017","unstructured":"Liss\u00a0MA, Ehdaie\u00a0B, Loeb\u00a0S et\u00a0al (2017) An update of the American urological association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J\u00a0Urol 198:329\u2013334","journal-title":"J Urol"},{"key":"1365_CR14","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","volume":"64","author":"S Loeb","year":"2013","unstructured":"Loeb\u00a0S, Vellekoop\u00a0A, Ahmed\u00a0HU et\u00a0al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64:876\u2013892","journal-title":"Eur Urol"},{"key":"1365_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41391-018-0032-2","volume":"21","author":"J Noreikaite","year":"2018","unstructured":"Noreikaite\u00a0J, Jones\u00a0P, Fitzpatrick\u00a0J et al (2018) Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 21:153\u2013160","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1365_CR16","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00345-016-1985-1","volume":"35","author":"L Pepdjonovic","year":"2017","unstructured":"Pepdjonovic\u00a0L, Tan\u00a0GH, Huang\u00a0S et al (2017) Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis. World J Urol 35:1199\u20131203","journal-title":"World J Urol"},{"key":"1365_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000814","author":"A Pilatz","year":"2020","unstructured":"Pilatz\u00a0A, Dimitropoulos\u00a0K, Veeratterapillay\u00a0R et al (2020) Antibiotic prophylaxis for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis. J\u00a0Urol. https:\/\/doi.org\/10.1097\/JU.0000000000000814","journal-title":"J Urol"},{"key":"1365_CR18","unstructured":"Pradere B, Veeratterapillay R, Dimitropoulos K et al (2020) Non-antibiotic strategies for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis. J\u00a0Urol"},{"key":"1365_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00345-017-2163-9","volume":"36","author":"MJ Roberts","year":"2018","unstructured":"Roberts\u00a0MJ, Scott\u00a0S, Harris\u00a0PN et al (2018) Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis. World J Urol 36:323\u2013330","journal-title":"World J Urol"},{"key":"1365_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijantimicag.2014.01.008","volume":"43","author":"MJ Roberts","year":"2014","unstructured":"Roberts\u00a0MJ, Williamson\u00a0DA, Hadway\u00a0P et al (2014) Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis. Int J Antimicrob Agents 43:301\u2013309","journal-title":"Int J Antimicrob Agents"},{"key":"1365_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.eururo.2013.05.030","volume":"64","author":"MJ Roobol","year":"2013","unstructured":"Roobol\u00a0MJ, Kranse\u00a0R, Bangma\u00a0CH et\u00a0al (2013) Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer. Eur Urol 64:530\u2013539","journal-title":"Eur Urol"},{"key":"1365_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.eururo.2009.08.025","volume":"57","author":"MJ Roobol","year":"2010","unstructured":"Roobol\u00a0MJ, Steyerberg\u00a0EW, Kranse\u00a0R et al (2010) A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer. Eur Urol 57:79\u201385","journal-title":"Eur Urol"},{"key":"1365_CR23","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1200\/JCO.2009.25.7311","volume":"28","author":"AE Ross","year":"2010","unstructured":"Ross\u00a0AE, Loeb\u00a0S, Landis\u00a0P et al (2010) Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a\u00a0prostate cancer surveillance program. J\u00a0Clin Oncol 28:2810\u20132816","journal-title":"J Clin Oncol"},{"key":"1365_CR24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/bju.14853","volume":"124","author":"W Venderink","year":"2019","unstructured":"Venderink\u00a0W, van Luijtelaar\u00a0A, van der Leest\u00a0M et al (2019) Multiparametric magnetic resonance imaging and follow-up to avoid prostate biopsy in 4259 men. BJU Int 124:775\u2013784","journal-title":"BJU Int"},{"key":"1365_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.eururo.2012.06.003","volume":"63","author":"FM Wagenlehner","year":"2013","unstructured":"Wagenlehner\u00a0FM, van Oostrum\u00a0E, Tenke\u00a0P et\u00a0al (2013) Infective complications after prostate biopsy: outcome of the global prevalence study of infections in urology (GPIU) 2010 and 2011, a\u00a0prospective multinational multicentre prostate biopsy study. Eur Urol 63:521\u2013527","journal-title":"Eur Urol"},{"key":"1365_CR26","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/j.urology.2013.12.069","volume":"84","author":"W Wang","year":"2014","unstructured":"Wang\u00a0W, Philpott-Howard\u00a0J, Nemade\u00a0H et al (2014) Variations in prostate biopsy practice between west and east: results of two national surveys. Urology 84:S76\u2013S77","journal-title":"Urology"},{"issue":"201","key":"1365_CR27","first-page":"e217","volume":"33","author":"L Yang","year":"2015","unstructured":"Yang\u00a0L, Zhu\u00a0Y, Tang\u00a0Z et al (2015) Antibiotics may not decrease prostate-specific antigen levels or prevent unnecessary prostate biopsy in patients with moderately increased prostate-specific antigen levels: a meta-analysis. Urol Oncol 33(201):e217\u2013224","journal-title":"Urol Oncol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-020-01365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-020-01365-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-020-01365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T07:41:52Z","timestamp":1634024512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-020-01365-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1365"],"URL":"https:\/\/doi.org\/10.1007\/s00120-020-01365-9","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"12 October 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Pilatz, G.\u00a0Bonkat und F.\u00a0Wagenlehner geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}